摘要
[目的]观察参松养心胶囊联合倍他乐克治疗老年心律失常疗效。[方法]使用随机平行对照方法,将100例患者按就诊顺序编号方法简单随机分为两组。对照组50例倍他乐克12.5~25mg/次,2次/d,口服。治疗组50例参松养心胶囊,1.6g/次,3次/d;倍他乐克治疗同对照组。连续治疗2周为1疗程。观测临床症状、心电图、用药后24h室性早搏次数、不良反应。治疗1疗程(2周),判定疗效。[结果]治疗组显效15例,有效31例,无效4例,总有效率92.00%;对照组显效10例,有效30例,无效10例,总有效率80.00%;两组无显著差异(P>0.05)。心电图疗效治疗组优于对照组(P<0.05);治疗24h后,室性早搏次数两组均有改善(P<0.01),治疗组改善优于对照组(P<0.01)。[结论]参松养心胶囊联合倍他乐克治疗老年心律失常,疗效满意,无严重不良反应,值得推广。
[Objective] To observe Shensongyangxin capsule combined with metoprolol in the treatment of senile arrhythmia effect. [Methods] 100 patients were randomly divided into two groups according to the random parallel control method. In the control group, 50 cases in cases, he was 12.5-25 mg/times, 2 times/ d, oral. The treatment group of 50 cases of Shensongyangxin capsule, 1.6 g/times, 3 times/d; betaloc treatment with the control group. Continuous treatment for 2 weeks for 1 courses. Observation of clinical symptoms, ECG, 24h after administration of ventricular premature beat frequency, adverse reaction. Treatment of 1 courses (2 weeks), to determine the efficacy. [Results] In the treatment group, 15 cases were markedly effective, 31 cases were effective, 4 cases were ineffective, the total effective rate was 92%; .the control group was 10 cases, effective 30 Cases, invalid 10 cases, the total effective rate was 80%; there was no significant difference between the two groups (P〉0.05). The control group ECG treatment group is better than the (P 〈0.05), 24h after treatment of ventricular premature beats in two groups were improved (P〈0.01), the treatment group was better than the control group (P〈0.01). [Conclusion] Shensong Yangxin capsule combined with metoprolol in the treatment of senile arrhythmia, satisfactory curative effect, no serious adverse reactions, worthy of nromotion.
出处
《实用中医内科杂志》
2017年第3期52-54,共3页
Journal of Practical Traditional Chinese Internal Medicine
关键词
老年心律失常
参松养心胶囊
倍他乐克
心电图
24h室性早搏次数
随机平行对照研究
senile arrhythmia
Shensong Yangxin capsule(参松养心胶囊)
metoprolol
electrocardiogram
24h the number of ventricular premature beat
randomized controlled study